SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.18 CNY | -0.28% |
|
+1.70% | -10.25% |
| Apr. 29 | Shanghai RAAS Blood Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 29 | RAAS Blood Products' 2023 Profit Falls 5% Despite 21% Revenue Growth | MT |
Evolution of the average Target Price on Shanghai RAAS Blood Products Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
0603ac2464f2f9ed0a99f5bfa.GDg8NBIc6FMm1LjcOVUFc9TptR6kFMNUOaAMIEVT2xU.dWBmd2JoogFMpOCfYQN1IuCcxH3heaYxDPROeSQVjX8gbg13Qm2_PnPlyw~b479d4e67f7677ac9f6bbb628e4f9d0f
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
7.18
CNY
Average target price
7
CNY
Spread / Average Target
-2.51%
High Price Target
7
CNY
Spread / Highest target
-2.51%
Low Price Target
7
CNY
Spread / Lowest Target
-2.51%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C-
EPS Revisions
- Stock Market
- Equities
- 002252 Stock
- Consensus Shanghai RAAS Blood Products Co., Ltd.
